Company
Headquarters: Jeddah, Saudi Arabia
SR7.30 Billion
SAR as of Jan. 1, 2025
US$1.94 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Middle East Healthcare Company, a healthcare provider, owns and operates a network of hospitals under the Saudi German Hospital name in the Middle East and North Africa. The company operates multi-specialty tertiary level hospitals, which comprise Saudi German HospitalÂJeddah with 218 beds; Saudi German Hospital-Aseer with 400 beds; Saudi German Hospital-Riyadh with 300 beds; Saudi German Hospital-Madinah with 300 beds; and Saudi German Hospital-Hail with 150 beds. Its multi-specialty tertiary care hospitals also include Saudi German Hospital-Dammam with 150 to 300 beds; Saudi German Hospital-Sanaa with 300 beds; Saudi German HospitalÂDubai with 300 beds; Saudi German HospitalÂSharjah with 50 beds; Saudi German HospitalÂAjman with 100-200 beds; and Saudi German Hospital-Cairo with 332 beds. The company was founded in 1988 and is based in Jeddah, the Kingdom of Saudi Arabia.
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | SR2.85 B |
| EBITDA | SR673.8 M |
| Gross Profit TTM | SR1.12 B |
| Profit Margin | 7.41% |
| Operating Margin | 15.83% |
| Quarterly Revenue Growth | 9.10% |
Middle East Healthcare Company has the following listings and related stock indices.
Stock: Tadawul: 4009 wb_incandescent